Abstract

BackgroundRed cell distribution width (RDW) reflects the volumetric heterogeneity of red blood cells (RBCs) and has proven to be a prognostic predictor for cardiovascular (CV) morbidity and mortality in ST-elevation myocardial infarction (STEMI). The study aims to evaluate the effect of the RDW admission value on the outcome of patients with STEMI.Materials and methodsThis is a cross-sectional observational study on (207) patients with first-ever STEMI, grouped according to their baseline RDW and thrombolysis eligibility into two groups. We calculated the in-hospital Global Registry of Acute Coronary Events (GRACE) score within 48 hours of presentation.ResultsThe study demonstrated the impact of RDW on the primary STEMI outcomes (left ventricular ejection fraction (LVEF%), ST-resolution, arrhythmias, and cardiovascular mortality risk). It was nearly a gender-matched study, with a mean RDW of 14.20±1.86%. RDW>14% and age≥65 years were the strongest statistically significant independent predictors of STEMI outcome with LVEF % < 45%, ST-resolution, and CV mortality regardless of thrombolysis. The thrombolysis offers a logical significant negative relation with CV mortality. At the same time, hypertension, diabetes mellitus (DM), and smoking may cause an additional mortality burden, especially in elderly patients with high RDW who are not eligible for thrombolysis. There was a significant association between high GRACE to high RDW, with excellent specificity and sensitivity in predicting CV outcome.ConclusionThe RDW is a simple to acquire index, with a good prognostic prediction of major adverse cardiovascular events (MACEs) and CV mortality in the STEMI patients. It is excellent in predicting STEMI outcomes, especially the response to thrombolysis.

Highlights

  • Red cell distribution width (RDW) is a measure of anisocytosis, representing the coefficient of variance of the mean corpuscular volume (MCV) [1,2]

  • The study demonstrated the impact of RDW on the primary ST-elevation myocardial infarction (STEMI) outcomes (left ventricular ejection fraction (LVEF%), ST-resolution, arrhythmias, and cardiovascular mortality risk)

  • There was a significant association between high Global Registry of Acute Coronary Events (GRACE) to high RDW, with excellent specificity and sensitivity in predicting CV outcome

Read more

Summary

Introduction

Red cell distribution width (RDW) is a measure of anisocytosis, representing the coefficient of variance of the mean corpuscular volume (MCV) [1,2]. The chronic inflammation, neurohumoral activation, macro- and micronutrient deficits may result in elevated RDW through diminished erythropoietin production, and increase red blood cell (RBC) deformability, and may reflect an epiphenomenon of the inflammatory or oxidative stress, mirroring a disordered RBC homeostasis [1,4,5,6,7,8]. It is a validated, novel prognostic biomarker or predictor for the poor outcome of several cardiovascular (CV) diseases and other underlying stresses that negatively impact erythropoiesis, and predispose to more atherosclerotic pathophysiological changes in coronary arteries [7,910]. The study aims to evaluate the effect of the RDW admission value on the outcome of patients with STEMI.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call